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Abstract 
The study aimed to identify the simplest protocol for the measurement of mean arterial pressure 
(MAP) across 10-40 weeks’ gestation. 2,726 women with uncomplicated singleton pregnancy 
attending for their routine hospital visit between 10-40 weeks’ gestation were recruited 
prospectively. The blood pressure (BP) was measured according to the National Heart 
Foundation of Australia (NHFA) protocol using automated devices. Linearizing regression 
models were determined for MAP derived from single, repeat and average measurements taken 
in the left and right arms using the same polynomial power of the best fit model determined 
using the NHFA protocol. Z-scores were used to compare the differences between the 
smoothed 50th percentiles. The first measurements taken in the left and right arms were on 
average 0.15SD and 0.12SD, respectively, higher than those obtained from the NHFA protocol. 
The second measurements taken in the left and right arms were both 0.26SD lower than the 
first measurement taken in the same arm and these values were lower than those from the 
NHFA protocol. The median MAP determined by the protocol of the average of two 
measurements taken in both arms was similar to the median MAP determined using the NHFA 
protocol (Z-score 0.0194SD). MAP derived by the average of two measurements in both arms 
had a quadratic relationship with gestation, with the measurement being the lowest in the mid-
trimester. In conclusion, our study has demonstrated that at 10-40 weeks’ gestation, BP 
recordings can be obtained by a simpler protocol using the average of two measurements in 
both arms.  
Keywords: Protocol, Mean arterial pressure, Blood pressure, Pregnancy, Hypertension, 
Preeclampsia, Reference range  
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Introduction   
In preeclampsia, hypertension develops as a result of vasoconstriction and reduced peripheral 
vascular compliance (1). Although hypertension is only a secondary sign of preeclampsia, it is 
an important one as it is an early indication of the condition. This highlights the importance of 
regular accurate monitoring of blood pressure during antenatal care. In the United Kingdom, the 
National Institute for Health and Care Excellence (NICE) has recommended that blood pressure 
measurement should be carried out at each antenatal visit to screen for preeclampsia (2). 
Within this recommendation, the protocol for blood pressure measurement is specific for the use 
of mercury sphygmomanometer (2). However, the use of mercury sphygmomanometers has 
been banned or phased out because mercury is toxic (3). There are also considerable errors 
associated with the use of the mercury sphygmomanometer. These errors range from a 
malfunctioning manometer to observer errors such as digit preference and threshold avoidance 
(4, 5).  
The introduction of automated blood pressure monitoring allows simple, standardized and 
repeated measurements to be taken. It has addressed many of the errors associated with the 
conventional sphygmomanometer. However, accurate assessment of blood pressure remains 
hindered by the considerable variability that blood pressure exhibits within each individual. The 
National Heart Foundation of Australia (NHFA) has therefore recommended that a minimum of 
two recordings should be made at 1-minute intervals until variations between consecutive 
readings fall to within 10 mmHg in systolic blood pressure and 6 mmHg in diastolic blood 
pressure (6). When this point of stability is reached, the average of the last two stable 
measurements of the left and right arms is calculated and it is recommended that the highest of 
these two measurements from the two arms should be used (6). Whether blood pressure should 
be taken on the left or right arm remains a subject of discussion. A difference between the two 
arms in the systolic and/or diastolic blood pressure of >10 mmHg was first reported in 1920 (7). 
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In the first-trimester of pregnancy, a significant inter-arm difference of >10 mmHg has been 
observed in a significant proportion of a healthy pregnant population and its prevalence 
increases with increasing blood pressure (8). For accurate risk assessment of preeclampsia at 
11-13 weeks’ gestation, a standardized protocol has been established that two measurements 
of mean arterial pressure (MAP) should be taken in both arms simultaneously (9). Such 
standardized protocol for the measurement of MAP throughout pregnancy has not been 
established. 
The objective of this study is to identify the simplest protocol for the measurement of MAP 
across 10-40 weeks’ gestation that could achieve comparable recordings to that obtained 
according to the NHFA protocol. 
 
Materials and methods 
 
This was a prospective cross-sectional study for establishing a protocol for MAP measurement 
in women with singleton pregnancy attending for their routine hospital visit between 10-40 
weeks’ gestation at King’s College Hospital, London. Gestational age (GA) was determined by 
the measurement of fetal crown-rump length at 11-13 weeks or the fetal head circumference at 
20-24 weeks (10, 11). The blood pressure was measured according to the NHFA protocol (6) 
and we recorded maternal characteristics and medical history. Written informed consent was 
obtained from the women agreeing to participate in the study, which was approved by the Ethics 
Committee of King’s College Hospital, London. 
We prospectively examined 3,002 singleton pregnancies. We excluded 276 (9.2%) because 
they had missing outcome data (n=77), loss follow up (n=73), there was a major fetal defect 
(n=3), the pregnancies resulted in fetal death or miscarriage before 24 weeks’ gestation (n=30), 
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the women underwent termination of pregnancy (n=3), the women developed preeclampsia 
(n=55), pre-gestational diabetes (n=9), and chronic hypertension (n=26). Therefore, a total of 
2,726 pregnant women were included in this study.  
 
Measurement of blood pressure 
 
Blood pressure was taken by validated automated devices (3BTO-A2, Microlife, Taipei, Taiwan), 
which were calibrated before and at regular intervals during the study (11). The recordings were 
made by doctors who had received appropriate training on the use of these machines. The 
women were in the sitting position, their arms were supported at the level of their heart and 
either a small (<22 cm), normal (22-32 cm) or large (33-42 cm) adult cuff was used depending 
on the mid-arm circumference (6). After rest for five minutes blood pressure was measured in 
both arms simultaneously and a minimum of two recordings were made at 1-minute intervals. 
When the last two blood pressure measurements in either arm differed by more than 10 mmHg 
in systolic and 6 mmHg in diastolic blood pressure, more recordings were made in both arms 
until variations between consecutive readings fell to within 10 mmHg in systolic and 6 mmHg in 
diastolic blood pressure. When this point of stability was reached, the MAP measurement of 
each arm was calculated as the average of the last two stable measurements, and as 
recommended, the highest final MAP from either arm was used (6). 
 
Patient characteristics  
 
Patient characteristics recorded included maternal age, racial origin (Caucasian, Afro-
Caribbean, South Asian, East Asian and mixed), method of conception (spontaneous or 
assisted conception requiring the use of ovulation drugs), cigarette smoking during pregnancy 
(yes or no), medical history of chronic hypertension (yes or no), diabetes mellitus (yes or no), 
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systemic lupus erythematosus or anti-phospholipid syndrome, family history of preeclampsia in 
the mother of the patient (yes or no) and obstetric history including parity (parous or nulliparous 
if no previous pregnancies at >24 weeks’ gestation), and previous pregnancy with preeclampsia 
(yes or no). The maternal weight and height were measured. 
 
Outcome measures 
 
Data on pregnancy outcome were collected from the hospital maternity records or the general 
medical practitioners of the women. The definitions of non-proteinuric gestational hypertension 
and preeclampsia were those of the International Society for the Study of Hypertension in 
Pregnancy (12). The obstetric records of all women with pre-existing or pregnancy associated 
hypertension were examined to confirm if the condition was chronic hypertension, preeclampsia 
or gestational hypertension. The newborn was considered to be small for GA if the birth weight 
was less than the 5th percentile after correction for GA at delivery (13).  
 
Statistical Analysis 
 
Paired samples t-test with Bonferroni adjustment was used to detect differences between 
measurements of systolic blood pressure, diastolic blood pressure, and mean arterial pressure 
taken in the left and right arms as well as between arms. Differences were considered 
significant if the adjusted p value was <0.05 / number of paired comparisons performed.   
     
The MAP derived from the NHFA protocol was used as a reference to determine the potential 
differences in MAP obtained using single, repeat and average measurements. The Generalized 
Additive Models for Location, Scale and Shape (GAMLSS package version 5.0, ‘R’ statistical 
software package version 3.3.2) was used to generate linearizing regression models as a 
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function of GA (polynomial or second degree fractional power) in order to estimate the expected 
MAP. The best fit model was determined for MAP derived using the NHFA protocol after 
measurements had been transformed to their natural log equivalent. Goodness of fit was 
assessed by inspecting residuals using quantile-quantile (Q-Q) plots and detrended Q-Q plots 
whilst the generalized Akaike information criterion was used to compare between different 
models (14, 15). The final model to estimate the mean MAP using the NHFA protocol was 
chosen as a balance between goodness of fit and model simplicity.   
 
Linearizing regression models were determined for MAP derived from single, repeat and 
average measurements taken in the left and right arms using the same polynomial power of the 
best fit model determined using the NHFA protocol. It was assumed that MAP had the same 
temporal relationship with gestation irrespective of measurement protocol. Z-scores were used 
to compare the differences between the smoothed 50th percentiles using the method described 
by Salomon et al (16). Expected gestation specific MAP from single, repeat and average 
measurements protocols were expressed as z-scores using the expression Z = ((XGA/μGA)
 1/ υ -1)/ 
υGAσGA where XGA is the 50
th percentile of MAP at a known GA determined using each protocol 
and υGA, μGA, and σGA are the Location, Mean and Scale values at any GA determined from the 
NHFA protocol. Results were presented graphically across the GA range to allow visual 
inspection. A z-score of 1 indicated a difference of 1 SD at that GA. Centiles were determined 
using the expression μ×(1+zpυGAσGA)
1/υGA where zp is the centile of interest. 
  
 
Results  
 
Characteristics of the study population 
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The MAP measurements were available for analysis from 2,726 women without pregnancy 
complications. The median (interquartile range; IQR) number of MAP recordings performed per 
gestational week was 48 (IQR: 34-68). There were 2,221 (81.5%) women requiring two 
recordings, 354 (13.0%) requiring three recordings, and 151 (5.5%) requiring four or more 
recordings. Clinical characteristics of the study population are demonstrated in Table 1.         
 
Intra- and Inter-arm measurement differences 
 
Table 2 reports the mean difference between the last two consecutive measurements taken in 
the left and right arms. The mean intra-arm differences were ≈3 mmHg for systolic blood 
pressure and 1 mmHg for diastolic blood pressure, whilst inter-arm differences were ≈-0.5 
mmHg for systolic blood pressure and ≈0.5 mmHg for diastolic blood pressure. Mean 
differences were statistically significant after Bonferroni adjustment. Absolute difference in 
consecutive systolic blood pressure measurements was ≥10 mmHg in 362 (13.5%) in the left 
arm and 357 (13.3%) in the right arm. Absolute difference in consecutive diastolic blood 
pressure measurements in the corresponding arms was ≥6 mmHg in 314 (11.7%) and 370 
(13.7%), respectively. A significant inter-arm difference of ≥10 mmHg in the first measurements 
of systolic and diastolic blood pressure was observed in 352 (13.1%) and 101 (3.8%) cases, 
respectively. The respective values for the second measurements were 319 (11.9%) and 72 
(2.7%).  
 
Mean arterial pressure reference range across gestation compared to the NHFA protocol 
 
The SD of MAP determined using the NHFA protocol, irrespective of gestation, was 7.31 
mmHg. Modelling indicated that MAP by the NHFA protocol exhibited a quadratic relationship 
with gestation, with the MAP being at its lowest in the mid-trimester. The best fit model for 
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median MAP as a function of GA in days determined from blood pressure taken using the NHFA 
protocol was given by the expressions median MAP: 
 
Log μ(GA) = 4.52355 – 0.00169796 × GA + 00000537401 × GA2; coefficient variation σ 
(GA) = e–3.962356 and skewness υ (GA) = 0.5111683 – 0.0272428 × GA  
 
Figure 1 displays the comparison of the gestational medians determined by the average of the 
first measurements, the average of the second measurements and the average of the first two 
measurements from both arms, relative to the median obtained using the NHFA protocol.  
 
Relative to the expected median value determined using the NHFA protocol, the first 
measurements taken in the left and right arms were on average 0.15SD and 0.12SD higher, 
respectively. The second measurements taken in the left and right arms were both lower than 
those obtained using the NHFA protocol as well as being 0.26SD lower than the first 
measurement taken in the same arm. The average of the first measurements from both arms 
was consistently higher than the NHFA median and the average of the second measurements 
was consistently lower than the NHFA median throughout pregnancy. The mean differences in 
Z-scores relative to the NHFA median of the average of the first and second measurements 
from both arms were 0.13 and -0.13, respectively.  There was a constant relationship between 
the median MAP determined by the protocol of the average of two consecutive measurements 
taken in both arms and the median MAP determined using the NHFA protocol (Figure 2). The 
mean difference in Z-scores between the two protocols (the average of both arms vs. the NHFA 
protocol) was 0.0194SD. 
 
Mean arterial pressure reference range across gestation according to the new protocol 
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The SD of MAP determined using the protocol of the average of two measurements in both 
arms, irrespective of gestation, was 7.29 mmHg. Modelling indicated that MAP by this protocol 
exhibited a quadratic relationship with gestation, with the MAP being at its lowest in the mid-
trimester (Table 3; Figure 3). The best fit model for median MAP as a function of GA in days 
determined from blood pressure taken using this protocol was given by the expressions median 
MAP: 
 
Log μ(GA) = 4.52594 – 0.00170796 × GA + 0.00000539256 × GA2; coefficient variation 
σ (GA) = e–3.9659578 and skewness υ (GA) = 0.5175562 – 0.0274941 × GA 
  
Relative to the expected median value determined using the new protocol, the first 
measurements taken in the left and right arms were on average 0.13SD and 0.10SD higher, 
respectively. The second measurements taken in the left and right arms were 0.14SD and 
0.16SD lower than those obtained using this protocol.  
 
 
Discussion 
 
Principal findings of the study 
 
The study has demonstrated that in establishing a protocol for MAP measurement at 10-40 
weeks’ gestation: (i) a single measurement in either the left or right arm deviates the most from 
that of the NHFA protocol, (ii) the average of the first measurements from both arms was 
consistently higher than the NHFA median and the average of the second measurements was 
consistently lower than the NHFA median throughout pregnancy, (iii) the MAP recorded 
according to the protocol of the average of two measurements in both arms is effectively 
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clinically equivalent to that determined using the NHFA protocol for purposes of screening, and 
(iv) the MAP exhibits a quadratic relationship with gestation, with the MAP being at its lowest in 
the mid-trimester. Our results suggest that, at 10-40 weeks’ gestation, blood pressure 
recordings can be obtained by a simpler protocol using the average of two measurements in 
both arms.  
 
Guidelines of blood pressure measurement  
 
There is increasing awareness of the need for specific guidelines for blood pressure 
measurement in pregnancy. In order to address the inter-arm difference in blood pressure, the 
updated guidelines from several professional bodies have advised that blood pressure should 
be measured in both arms and the arm with the higher blood pressure value should be chosen 
for subsequent blood pressure measurements throughout pregnancy (17-21).  In particular, the 
updated NHFA guideline now recommends that blood pressure should be measured at least 
three times in both arms and the average of the last two recordings should be used (20). 
Moreover, blood pressure between both arms should vary by <10 mmHg. If the blood pressure 
between both arms is >10 mmHg, one to two additional measurements should be taken and the 
average of these repeated recordings should be used (18, 19). Currently, these 
recommendations are not implemented worldwide. They have not addressed the issue of blood 
pressure variability exhibited within each individual and they do not provide explicit guidance on 
whether blood pressure should be measured repeatedly until a necessary point of stability is 
achieved. 
 
Our group has strictly followed the guideline proposed by the NHFA (6). We have previously 
confirmed that in first trimester screening for preeclampsia by MAP, the best performance is 
provided by following the NHFA protocol (9). However, a new first trimester protocol, which 
  
12 
 
utilizes a simpler approach of using the average of two recordings in each arm, has been 
developed because, in order to achieve the necessary point of stability in blood pressure 
according to the NHFA protocol, it is necessary to perform a minimum of two measurements in 
both arms in about 50% of cases, three measurements in 25% of cases and four measurements 
in 25% (9). The respective figures observed in this study were 81%, 13% and 6%. 
 
Blood pressure profile 
 
The findings that there is a quadratic relationship between MAP and gestation, with the MAP 
being at its lowest in the mid-trimester (22-24), and that there is a significant inter-arm difference 
in blood pressure, are in agreement with previous studies (8, 25, 26). Although a large 
difference in blood pressure between the two arms is a common finding in certain pathological 
conditions, such as dissection or coarctation of the aorta, peripheral vascular disease and 
unilateral neurological and musculoskeletal abnormalities (27), it is also found in normal healthy 
individuals (28, 29). Possible explanations for an inter-arm blood pressure difference in healthy 
individuals include anatomical variations such as the angulation and branching of aorta, 
differences in vascular resistance (30), and compression of the subclavian artery that supplies 
the arm by surrounding muscles or structures (31). The inter-arm blood pressure difference has 
also been shown to be an indicator of long-term cardiovascular risk (32, 33) and mortalities (34, 
35). With pregnancy being a window of opportunity for a healthcare system to screen most 
women of reproductive age for risk factors of cardiovascular disease, it is therefore essential to 
measure blood pressure in both arms as part of routine antenatal care.  
 
Strengths and weaknesses 
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The strengths of the study include the measurement of blood pressure in both arms 
simultaneously using validated automated devices across 10-40 weeks’ gestation in a large 
normal pregnancy population using a standardized protocol. To date, there are no reference 
range studies that have simultaneously measured blood pressure in both arms and repeatedly 
until the blood pressure becomes stable. The main limitation of the study is that due to the 
nature of antenatal care it was not possible to recruit more cases before 10 weeks and after 40 
weeks’ gestation.  
 
Conclusion 
 
Measurement of blood pressure remains an important component of routine antenatal care. In 
our study, appropriately trained doctors have used validated automated devices to measure 
MAP in a large population of pregnant women at 10-40 weeks’ gestation. As the NHFA protocol 
is considered complex and time consuming, this study has established that the measurement of 
MAP can be obtained by a simpler protocol using the average of two measurements in both 
arms.  
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Figure legends 
 
Figure 1. Comparisons of the expected 50th percentile of mean arterial pressure (MAP) of the 
first left and right average (_._._), second left and right average (_.._.._), and the average of the 
first and second measurements in both arms (-----), relative to the expected 50th percentile of 
MAP derived from the National Heart Foundation of Australia protocol (NHFA; ___). 
 
Figure 2. Comparisons of the expected 50th percentile of mean arterial pressure (MAP) of the 
average of the first two measurements in the left arm (…..), right arm (_.._) and both arms (-----) 
relative to the expected 50th percentile of MAP derived from the National Heart Foundation of 
Australia protocol (NHFA; ___).  
 
Figure 3. Reference range of mean arterial pressure by the protocol of the average of the first 
two measurements in both arms across 10-40 weeks’ gestation.  
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Table 1. Maternal characteristics in the study population. 
 
Maternal characteristic n=2,726 
Maternal age in years, median (IQR) 31.2 (26.8-
35.2) 
Body mass index in Kg/m2, median (IQR) 25.7 (22.9-
28.9) 
Racial origin  
   Caucasian, n (%) 1,213 (44.50%) 
   Afro-Caribbean, n (%) 957 (35.10%) 
   South Asian, n (%) 295 (35.11%) 
   East Asian, n (%) 89 (3.26%) 
   Mixed, n (%) 172 (6.31%) 
Parity  
   Nulliparous, n (%) 954 (35.0%) 
   Parous – no previous preeclampsia, n (%) 542 (19.88%) 
   Parous – previous preeclampsia, n (%) 1,230 (45.12%) 
Cigarette smoker, n (%) 206 (45.12%) 
Family history of preeclampsia – Mother (n, 
%) 
67 (2.46%) 
Conception  
   Spontaneous, n (%) 2,664 (97.43%) 
   Ovulation drugs, n (%) 43 (1.54%) 
   In-vitro fertilization, n (%) 19 (0.70%) 
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Table 2. Intra- and Inter-arm blood pressure measurement differences 
Blood pressure parameter Mean Difference ± SD  
(mmHg) 
P# 
Systolic blood pressure   
Left first vs second 2.970 ± 5.952 <0.001 
Right first vs second 3.022 ± 6.192 <0.001 
Left first vs right first -0.573 ± 6.988 <0.001 
Left second vs right second -0.521 ± 6.513  <0.001 
   
Diastolic blood pressure   
Left first vs second 1.123 ± 3.525 <0.001 
Right first vs second 1.044 ± 3.759 <0.001 
Left first vs right first 0.610 ± 4.445 <0.001 
Left second vs right second 0.529 ± 4.124 <0.001 
   
Mean arterial pressure   
Left first vs second 1.781 ± 3.278 <0.001 
Right first vs second 1.693 ± 3.403 <0.001 
Left first vs right first 0.264 ± 4.061 <0.001 
Left second vs right second 0.177 ± 3.851 0.017 
Left mean vs right mean 0.211 ± 3.464 0.002 
 
# P-value considered significant if p< (0.05/13) after Bonferroni adjustment.  
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Table 3. Reference range of mean arterial pressure using the protocol of the average of the first 
two measurements taken in both arms.  
Gestational 
Week 
n Mean arterial pressure percentile 
3rd  10th 50th 90th 97th  
<10 88 72.3 75.8 84.2 94.1 99.3 
11 326 71.9 75.4 83.6 93.5 98.7 
12 354 71.6 74.9 83.2 92.9 98.2 
13 373 71.2 74.6 82.7 92.5 97.7 
14 149 70.9 74.2 82.3 92.0 97.2 
15 101 70.7 74.0 82.0 91.6 96.9 
16 68 70.4 73.7 81.7 91.3 96.6 
17 52 70.3 73.5 81.4 91.0 96.3 
18 45 70.1 73.3 81.2 90.8 96.1 
19 32 70.0 73.2 81.0 90.6 95.9 
20 32 69.9 73.1 80.9 90.5 95.8 
21 28 69.9 73.0 80.8 90.4 95.8 
22 107 69.9 73.0 80.7 90.4 95.8 
23 229 69.9 73.0 80.7 90.4 95.9 
24 38 70.0 73.0 80.8 90.5 96.0 
25 30 70.1 73.1 80.8 90.6 96.1 
26 60 70.2 73.3 81.0 90.8 96.4 
27 40 70.4 73.4 81.1 91.0 96.6 
28 34 70.6 73.6 81.3 91.3 97.0 
29 41 70.8 73.9 81.6 91.6 97.4 
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30 46 71.1 74.1 81.9 92.0 97.8 
31 30 71.4 74.5 82.2 92.4 98.3 
32 54 71.8 74.8 82.6 92.9 98.8 
33 34 72.2 75.2 83.1 93.4 99.5 
34 53 72.6 75.7 83.5 94.0 100.1 
35 61 73.1 76.1 84.1 94.6 100.9 
36 67 73.6 76.7 84.6 95.3 101.7 
37 46 74.1 77.2 85.3 96.1 102.5 
38 46 74.7 77.8 85.9 96.9 103.5 
39 40 75.4 78.5 86.7 97.8 104.5 
>40 23 76.0 79.2 87.4 98.7 105.5 
 
Percentiles determined using the following mean, coefficient of variation and skewness 
Log μ(GA) = 4.52594 – 0.00170796 × GA + 0.00000539256 × GA2 
coefficient variation σ (GA) = e–3.9659578  
skewness υ (GA) = 0.5175562 – 0.0274941 × GA  
where GA is gestational age in days 
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Highlight 
 Hypertension is an important sign of preeclampsia, therefore accurate blood pressure 
monitoring during antenatal care is essential 
 
 Due to considerable variability of blood pressure within each individual, National Heart 
Foundation of Australia (NHFA) has recommended to measure blood pressure until the 
variations between consecutive readings fall to within 10 mmHg in systolic blood 
pressure and 6 mmHg in diastolic blood pressure for both arms. 
 
 
 There is no standardized protocol for the measurement of blood pressure throughout 
pregnancy. 
 
 The mean arterial pressure (MAP) obtained from the average of two measurements in 
both arms is effectively clinically equivalent to that determined using the NHFA protocol. 
 
 
 At 10-40 weeks’ gestation, blood pressure recordings can be obtained by a simpler 
protocol using the average of two measurements in both arms instead of following the 
NHFA protocol, which is complex. 
 
